Sunday, November 03, 2019 5:54:21 PM
The new patent could certainly be worth triple digit share prices based on the current O/S if clinical trials demonstrate the patent is right about the benefits. Hopefully the clinical trials won't be too far off as I know people I'd suggest them to.
We're at a period in medical treatment where advances are coming from many directions. I believe the work the PSTI is doing will achieve major benefits, but so will others, and in the end treatment that's most successful may take in at least a couple of the more recent advances.
Gary
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM